| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Tuesday’s Close |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Limited | $23.43 | $23.86B | N/A |
Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe
http://www.zacks.com/stock/news/728495/novartis-nvs-gets-approval-for-ms-drug-mayzent-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-728495
Jan 21, 2020 - Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.
0
Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal
http://www.zacks.com/stock/news/748888/tevas-two-pivotal-studies-on-ajovy-in-japan-meet-goal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-748888
Feb 04, 2020 - Teva (TEVA) posts positive results from two phase II/III studies on Ajovy for treating patients with chronic and episodic migraine in Japan.
0
Teva Reports Q4 Earnings Beat
http://feeds.benzinga.com/~r/benzinga/~3/tEL9UqI1Dk4/teva-reports-q4-earnings-beat
Feb 12, 2020 -
Teva Pharmaceutical Indus (NYSE: TEVA) reported fourth-quarter earnings of 64 cents per share, which beat the analyst consensus estimate of 61 cents by 4.92%. This is a 20.75% increase over earnings of 53 cents per share from the same period last year.
0
Teva (TEVA) Q4 Earnings In Line, Sales Beat, Stock Up
http://www.zacks.com/stock/news/761874/teva-teva-q4-earnings-in-line-sales-beat-stock-up?cid=CS-ZC-FT-tale_of_the_tape|earnings_report-761874
Feb 12, 2020 - Teva Pharmaceutical (TEVA) matches earnings estimates but beats the same for sales. Shares rise in pre-market trading.
0
Why Teva Pharmaceutical Is Rallying 10% Today
https://www.fool.com/investing/2020/02/12/why-teva-pharmaceutical-is-rallying-10-today.aspx?source=iedfolrf0000001
Feb 12, 2020 - The company's latest financial results are sparking investor optimism.
0
Teva Pharmaceutical Industries Limited 2019 Q4 - Results - Earnings Call Presentation
https://seekingalpha.com/article/4323413-teva-pharmaceutical-industries-limited-2019-q4-results-earnings-call-presentation?source=feed_tag_israel
Feb 12, 2020 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2019 Q4 earnings call.
0
Leaner, More Agile Teva Has Brighter Days Ahead
http://www.gurufocus.com/news/1038203/leaner-more-agile-teva-has-brighter-days-ahead
Feb 13, 2020 - Leaner, More Agile Teva Has Brighter Days Ahead, Stocks: TEVA,AMGN,LLY, release date:Feb 13, 2020
0
Leaner, More Agile Teva Sees Brighter Days Ahead
http://www.gurufocus.com/news/1038203/leaner-more-agile-teva-sees-brighter-days-ahead
Feb 13, 2020 - Leaner, More Agile Teva Sees Brighter Days Ahead, Stocks: TEVA,AMGN,LLY, release date:Feb 13, 2020
0
Teva: The Road To Perdition Has Turned Into A Path Towards Redemption
https://seekingalpha.com/article/4325166-teva-road-to-perdition-turned-path-towards-redemption?source=feed_tag_israel
Feb 19, 2020 - Stock price has bounced significantly, debt load has declined substantially, and bond yields have fallen meaningfully.More than anything, the recent earnings report has proven that the company remains
0
3 Reasons Why Teva Pharmaceutical Is Still A Good Buy
https://seekingalpha.com/article/4325291-3-reasons-why-teva-pharmaceutical-is-still-good-buy?source=feed_tag_israel
Feb 19, 2020 - Teva exceeded market expectations in the fourth quarter.Prospects continue to improve, driven by strong generic pipeline and two drugs.Fair value on Teva stock modelled.
0